Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Pandion Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Unicorn

Pandion Therapeutics is Cambridge based healthcare Startup

Valuation
$1.85B
Market cap · 2026
Revenue
$6.6M
Latest reported FY

Investors

8 investors on Pandion Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 5 investors entered at this stage
Versant Ventures
Roche Venture Fund
SR One
BioInnovation
Polaris Partners
Series B+ 3 investors entered at this stage
Boxer Capital
RA Capital Management
Access Biotechnology

Global footprint

Where Pandion Therapeutics has talent and traffic

Workforce by country
🇺🇸 United States · Cambridge HQ
Book a demo for the full country breakdown

Patent intelligence

$7M patent portfolio · 18 active families

Estimated portfolio value
$7M
0.39% of market cap · 3.6× smaller than top peer Kymera Therapeutics ($26M)
18 active patent families
Where Pandion Therapeutics innovates BiochemistryMolecular biologyImmunologic ToleranceImmune privilegeLocal immunity

Where Pandion Therapeutics concentrates vs peers

Each axis is a top-10 topic across Pandion Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Pandion Therapeutics

An AI-synthesized read of the highest-engagement posts about Pandion Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Pandion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.